Lifecycle management

We develop impactful, integrated commercial and clinical strategy across the lifecycle of products – from pre-launch excellence response to market changes and end-of-lifecycle products.

Working in cross-functional, commercial and medical teams, we work with you to develop strategy to challenge the dynamic and competitive market you operate in.

Case study

Brand repositioning

view more

Case study

EU launch for US client

view more

Case study

Global launch in competitive urology market

view more
Related articles
sketchnote-blue-latitude-health-portfolio-planning

Bigger than brand: Portfolio positioning for pharma

Jenna Earl | 29th September 2015

With pharma in the midst of a patent cliff, portfolios of treatments are becoming more and more common, and the need for a clear co-positioning strategy has never been greater.

Head of Brand Strategy Jenna Earl talks us through the three most important things to understand about portfolio positioning in pharma.

read more

clinic-medical-scientist-medicine-lab

Tackling biosimilars – how to handle the threat to pharma brands

Mark Assenti | 23rd September 2015

Recently, Blue Latitude Health worked with a global pharmaceutical brand to develop a strategy for dealing with the introduction of biosimilars to the market. Their product, a treatment in the gastroenterology therapy area, had recently come off patent and a biosimilar was about to launch. Strategy Consultant Mark Assenti talks through three key points for developing a strategy to tackle biosimilars.

read more

one-way-road-sign-sepia-tone-photo

How to nail pre-launch positioning in pharma

Matt Bolton | 22nd July 2015

Recently, we’ve worked across multiple brands in oncology on launch and pre-launch strategy, which raises a unique set of challenges in a competitive and highly regulated market. Matt Bolton, Head of Commercial, takes us through the three key points to keep in mind when developing a pharmaceutical pre-launch positioning strategy.

read more

microscope-dna-Blue-Latitude-Health-biomarkers-in-marketing

Use of biomarkers in marketing

Mark Assenti | 12th March 2015

The modern pharmaceutical market can be saturated with competing products, from bio-similars, to same in-class, to alternative MoA treatments. Standing out from the crowd can be tough; innovative and patient serving methods of differentiation are hard to come by. 

Consultant Mark Assenti talks through the use of biomarkers in pharma marketing and where it's headed in 2015.

read more